Results 171 to 180 of about 345,615 (256)

Plasma metabolomic signatures in patients with multidrug-resistant bacterial sepsis. [PDF]

Metabolomics
Wang J, Luo G, Lv P, Li Q, Yu S, Chen Y, Yu L, Li K.   +7 more
europepmc   +1 more source

Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid Cancer

International Journal of Cancer, EarlyView.
Although lenvatinib is the current first‐line therapy for radioiodine‐refractory differentiated thyroid carcinoma, its use is limited by severe side effects and reduced sensitivity. Here, the authors assessed the potential of sensitizing differentiated thyroid carcinoma tumor cells with limited lenvatinib responsiveness through the administration of ...
Celina Ablinger, Petra Huber‐Cantonati, Daniela D. Weber, Sarah Pichler, Georg Schischkow, Marta Garcia‐Miralles, Christian Pirich, Gundula Rendl, Teresa Kiener, Thomas Felder, Martin Geroldinger, Robert Terkola, Barbara Kofler, Johanna Pachmayr   +13 more
wiley   +1 more source

Migratory Birds Facilitate the Spread of Multidrug-Resistant Pathogenic Escherichia coli in Tanguar Haor of Bangladesh. [PDF]

Environ Microbiol Rep
Khatun MN, Chakraborty S, Akter T, Ifte JS, Begum JA, Islam MA, Parvin R, Hossain MT, Chowdhury EH.   +8 more
europepmc   +1 more source

Multidisciplinary Strategies for Targeting Tumor Dormancy in Breast Cancer Therapeutics: Hallmarks, Mechanism, and Approaches

iMetaMed, EarlyView.
Clinical phases and classification of breast tumor dormancy. Tumor dormancy is described as the period after treatment until residual tumor cells become detectable as relapsing disease in clinic. During the period of clinical tumor dormancy, tumor mass dormancy and cellular dormancy may coexist.
Shu Chen, Hui Chen, Vijaya Raghavan, Jing Huang, Jin Wang   +4 more
wiley   +1 more source

Phage-antibiotic combination: a possible approach to combatting multidrug-resistant Klebsiella pneumoniae. [PDF]

AMB Express
Abdelhakim NI, Alshareef WA, Saleh SE, Yassein MA.   +3 more
europepmc   +1 more source

Substrate Characterization of Mycobacterial Kinase PknG Revealing PknG‐KARS‐MAPK Phosphorylation Signaling Axis in Host

iMetaMed, EarlyView.
This study employed multi‐omics approaches to investigate the regulatory mechanism of Mycobacterium PknG on host cell processes. We found that host lysine‐tRNA ligase (KARS) is a potential substrate of PknG; and PknG can regulate the immune response by catalyzing the phosphorylation of KARS at T592 and T595 sites, affecting the phosphorylation level in
Nana Tian, Shuyu Xie, Yanqing Tang, Junjie Liang, Wenhan Zhu, Tianqi Liu, Yewen Sun, Yang Yang, Luoxi Zhang, Danfeng Wang, Chuyao Lin, Jinyu Jia, Minjia Tan, Jun‐Yu Xu   +13 more
wiley   +1 more source

Decolonizing the gut from multidrug-resistant bacteria: Current strategies and future perspectives. [PDF]

World J Methodol
Mishra A, Juneja D.
europepmc   +1 more source

Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection [PDF]

, 2018
Burnham, Jason P., Kollef, Marin H., Rojek, Rebecca P.   +2 more
core   +1 more source

L‐EasyARG: A long‐read metagenomics tool for rapid antibiotic‐resistance‐gene profiling

iMetaOmics, EarlyView.
L‐EasyARG is a pipeline for long‐read metagenomic profiling of antibiotic resistance genes (ARGs) and their genetic context. It integrates ARG identification, plasmid and mobile genetic element (MGE) detection, taxonomic classification, and further identifies ARGs carried by human bacterial pathogens (HBPs) defined in the WHO and ESKAPE pathogen lists.
Yongxin Li, Mingchao Wang, Xiaohui Liu, Junhua Wu, Yujie Mao, Caili Zhang, Qingru Chen, Zhi Wang, Gongchao Jing, Maozhen Han   +9 more
wiley   +1 more source

Fosfomycin combination therapy in high-risk paediatric patients with multidrug-resistant infections: a retrospective study. [PDF]

Eur J Pediatr
Denina M, Badiali L, Vitale R, Robasto F, Funiciello E, Silvestro E, Pruccoli G, Garazzino S.   +7 more
europepmc   +1 more source